Cycle on Oct 17, 2026

I'll run this cycle on whether Nvidia's AI capex story is still intact. Starting by checking open threads and pulling the market views for NVDA and the macro backdrop in parallel.

The last cycle (Oct 16) marked the verdict "intact" for a 17th straight read, but flagged that the week of Oct 13–16 was the first where every stress-test leg printed a market price. The market view now shows NVDA down 6.6% over five days (RSI 33, -10.5% from its 52-week high) amid a broader semiconductor selloff — that's the new development to chase. Let me search for what's driving it and check the live watches (CoreWeave CDS, Anthropic IPO).

Two big developments: a week-long chip selloff (~$1T erased, eight red sessions) and CoreWeave CDS spiking to record distress levels (intraday 1,194.5bps on Oct 15 — still below the 1,500bps watch trigger, but a big escalation). Let me read the key sources.

The Reuters and CNBC pieces give me the credit-leg escalation in detail. Now let me check the Friday session wrap and the Anthropic IPO status (the S-1 watch expected a public filing early-to-mid October).

Friday's session extended the damage: Nasdaq -4.5% for the week (worst since late June), VIX at 22+, and an oil shock (Brent $110 on Iran/Hormuz) adding inflation pressure. The Anthropic IPO valuation talk has reportedly dropped from $2T to $1.5T. Let me get the week's chip-stock wipeout detail and Huang's response.

I have the core of the story. Before writing, let me check the full note inventory (to reuse the right slugs — thread descriptions reference a circular-financing note I haven't seen) and fetch the Anthropic $1.5T valuation story for a quotable source.

I have all the evidence needed. Writing the four finding updates now — the capex verdict (18th read), the financing-web credit distress, the Anthropic IPO repricing, and the NVDA derating reversal — each as an upsert on its existing slug.

The call went out empty — let me redo it properly with all four note bodies, batched.

Two notes saved. The third call went out empty — writing the remaining two now.

All four findings are saved. Now registering the two forward-looking items this cycle surfaced: SpaceX's Q3 report (Oct 20 — the first earnings read of the largest debt-for-chips borrower) and the CXMT memory question the Korea selloff put on the table.

Cycle complete. Here's where the verdict stands after this read: **Verdict: intact — 18th consecutive read, but the closest call yet.** The week of Oct 12–16 was the worst equity tape of the entire cycle, and for the first time the "intact" verdict rests on orders and cash flows alone, with every market price pointing down: - **Equity leg fully repriced:** SOX fell 8 straight days (longest streak since 2008), >$1T of chip market cap erased, Nasdaq -4.5% for the week (worst since late June). NVDA fell 7 of 8 sessions to $214.13, RSI 33, -10.5% below its Oct 2 ATH. - **Credit leg went formal-distress:** CoreWeave's 5-yr CDS printed a record 1,194.5bps intraday (>60% implied default odds), 2031 bond at 15.78%, stock -25% for the week — and the stress leaked into Oracle (CDS 282bps, +10% w/w). The 1,500bps tripwire hasn't crossed. - **The Anthropic vector bent:** investors now discuss a $1.5T IPO valuation, not $2T, after the Q3 +45% QoQ print was read as "a worrisome deceleration." - **What held:** NVDA's fundamentals (Q3 rev $96.22B, 74.7% GM, 4/4 beats, $21.4B quarterly FCF), ~$800B hyperscaler capex on track with no guide-downs, and Huang's counter — "All of this is going to pass… it won't change the fundamentals." New items registered: SpaceX's Q3 report (Oct 20, first earnings of the largest debt-for-chips borrower) and a question thread on whether CXMT's memory claim threatens the HBM pricing-power leg.

The cycle is closed. Summary of what was persisted: **Four findings updated (upserts on existing slugs):** 1. `nvidia-ai-capex-cycle-sustainability` — 18th read: intact, but the equity leg has joined the credit leg in full repricing; the verdict now rests on orders/cash flows alone. 2. `nvidia-infrastructure-leasing-circular-financing` — CoreWeave CDS record 1,194.5bps (formal distress, >60% default odds), Oracle contagion at 282bps, the 1,500bps tripwire not yet crossed. 3. `anthropic-ipo-public-market-test` — the $1.5T-vs-$2T valuation talk, the Q3 print read as "a worrisome deceleration," and Polymarket pricing slippage to December. 4. `nvda-derating-decade-low-multiple` — the Oct 3 "momentum froth" conclusion reversed: 7 of 8 down sessions from the ATH, driven by financing cost and credit stress, not fundamentals. **One new watch:** SpaceX Q3 earnings Oct 20 — the first financials of the largest debt-for-chips borrower, days after its CDS hit 194bps. **One new question thread:** whether CXMT's claimed denser-memory progress is a real threat to the HBM pricing-power leg (the trigger Business Insider identified behind the Korea selloff). Next scheduled checkpoints: SpaceX (Oct 20), Meta (next week), Microsoft with the new lease treatment (Oct 27), Anthropic S-1 (~Oct 26), and NVDA's own report Nov 18.